Intellipharmaceutics International Inc. (IPCIF)

IPCIF Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	4	2	4	3	3	2
Market Cap Growth	-11.11%	-34.41%	15.30%	-5.37%	105.98%	-94.04%
Enterprise Value	6	5	6	4	5	-3
PE Ratio	-	-0.80	-1.22	-0.60	-0.95	-0.11
PS Ratio	4.25	35.24	53.73	2.19	2.31	0.92
PB Ratio	-0.21	-0.22	-0.33	-0.38	-0.51	0.38
P/FCF Ratio	31.90	-1.67	-2.54	-1.24	29.91	-0.12
P/OCF Ratio	31.90	-1.67	-2.54	-1.24	28.87	-0.13
EV/Sales Ratio	6.26	69.36	87.84	3.00	3.67	-1.92
EV/EBITDA Ratio	-1.86	-1.72	-2.18	-1.08	-2.92	0.25
EV/EBIT Ratio	-1.73	-1.60	-2.03	-1.01	-2.36	0.24
EV/FCF Ratio	46.99	-3.28	-4.16	-1.71	47.56	0.26
Debt / Equity Ratio	-0.17	-0.22	-0.22	-0.24	-0.33	0.44
Debt / EBITDA Ratio	-0.92	-0.88	-0.88	-0.49	-1.20	-0.14
Debt / FCF Ratio	18.42	-1.68	-1.68	-0.78	19.52	-0.14
Quick Ratio	0.05	0.04	0.04	0.10	0.13	1.48
Current Ratio	0.06	0.04	0.04	0.11	0.15	1.64
Asset Turnover	0.55	0.05	0.05	0.67	0.41	0.15
Interest Coverage	-26.72	-9.77	-9.77	-7.60	-4.82	-52.21
Return on Equity (ROE)	24.65%	27.35%	27.35%	63.09%	53.71%	-334.91%
Return on Assets (ROA)	-202.69%	-201.98%	-201.98%	-245.43%	-100.12%	-119.74%
Return on Capital (ROIC)	24.21%	34.55%	34.55%	66.90%	111.36%	-226.15%
Earnings Yield	-82.60%	-124.86%	-81.90%	-167.97%	-104.76%	-874.23%
FCF Yield	3.13%	-59.93%	-39.31%	-80.48%	3.34%	-802.40%
Buyback Yield / Dilution	0.00%	-12.45%	-24.90%	-9.18%	-353.15%	-53.55%
Total Shareholder Return	0.00%	-12.45%	-24.90%	-9.18%	-353.15%	-53.55%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.